Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Knee Bursitis Market Size Shifted, And What Is the Outlook Through 2034?

The market for knee bursitis has seen robust growth in recent times, with projections indicating a rise from $2.66 billion in 2024 to $2.86 billion in 2025. This equates to a compound annual growth rate (CAGR) of 7.6%. This surge during the historic period can be credited to a number of factors, including an aging population, a rise in engagement in sports and physical activities, advancements in diagnostic processes, improved healthcare accessibility, as well as educational programs aimed at healthcare professionals and patients.

How Much Will the Knee Bursitis Market Be Worth in 2029?

Expectations are high for the knee bursitis market to experience robust growth in the following years. The forecasted growth rate suggests a potential value of $3.79 billion in 2029, representing a compound annual growth rate (CAGR) of 7.3%. This projected growth over the forecast period is largely due to factors such as heightened awareness campaigns focussing on prevention and management, an increase in disposable income, rising healthcare expenditure, in addition to improved awareness and diagnosis of knee bursitis. Key trends for the forecast period take into account advancements in diagnostic technologies, the creation of unique therapies, consistent progress in research and development, and the increasing integration of telemedicine and remote monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which is the Largest Company in the Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

What Are the Main Market Drivers in the Knee Bursitis Industry?

The proliferation of bone-related diseases is anticipated to fuel the knee bursitis market’s expansion. Conditions such as osteoporosis, arthritis, and bone cancer fall under bone-related diseases, impacting the skeletal system’s structure, strength, and functionality. Aging populations, sedentary lifestyles, inadequate nutrition, and environmental shifts contribute to the rising prevalence of these diseases. Bone diseases like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by inducing inflammation and overwhelming pressure on the knee bursa, leading to pain, swelling, and decreased joint function. For example, Healthy Bones Australia, a non-profit organization in Australia, projected in September 2022 that in 2022, an estimated 6.2 million individuals over the age of 50 in Australia would suffer from osteoporosis or osteopenia. This estimate is based on the assertion that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Therefore, the escalating prevalence of bone-related ailments is encouraging the growth of the knee bursitis market. Issues related to the increasing prevalence of diabetic population are predicted to push the growth of the knee bursitis market. Diabetes is a long-term disease in which the body struggles to maintain the right blood sugar levels due to inadequate insulin manufacture or ineffective insulin application. Factors such as sedentary lifestyles, poor food habits, and genetic predispositions contribute to the rise in diabetes cases. Diabetic individuals are prone to knee bursitis due to inflammation brought on by constant pressure on the knees, weakened immune function, or diabetes-related complications. For instance, a June 2024 report from the National Health Service (NHS), a public health organization based in the UK, noted a significant increase in people diagnosed with pre-diabetes – 3,615,330 in 2023, up from 3,065,825 in 2022, representing an 18% increase. Therefore, the growing diabetic population is pushing the knee bursitis market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

How Is the Knee Bursitis Market Segments Structured?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound

2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Global Regions Offer the Highest Growth in the Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

This Report Delivers Insight On:

1. How big is the knee bursitis market, and how is it changing globally?

2. Who are the major companies in the knee bursitis market, and how are they performing?

3. What are the key opportunities and risks in the knee bursitis market right now?

4. Which products or customer segments are growing the most in the knee bursitis market?

5. What factors are helping or slowing down the growth of the knee bursitis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model